We are live on ! Find out more
MTFB

Motif Bio plc ADRs
MTFB

Delisted

MTFB was delisted on the 16th of December, 2019.

Back to rankings

6 hedge funds and large institutions have $950K invested in Motif Bio plc ADRs in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 3 → 6 (+3)

54% less capital invested

Capital invested by funds: $2.06M → $950K (-$1.11M)

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$253K
2
Deutsche Bank
Deutsche Bank
Germany
+$161K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.5K
4
Citadel Advisors
Citadel Advisors
Florida
+$41K
5
VF
Virtu Financial
New York
+$14.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
1
Invesco
Georgia
$731K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$97K +$253K +145,350 New
Deutsche Bank
3
Deutsche Bank
Germany
$62K +$161K +92,605 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$26K +$46.5K +26,740 +207%
VF
5
Virtu Financial
New York
$19K +$14.1K +8,102 +41%
Citadel Advisors
6
Citadel Advisors
Florida
$15K +$41K +23,606 New

MTFB Hedge Fund Activity: Q2 2019 in Review

6 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q2 2019, worth a combined $950K — down 54% from $2.06M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MTFB positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $253K.

  • 6 institutional investors held Motif Bio plc ADRs (MTFB) as of Q2 2019, up from 3 in Q1 2019.
  • Funds reported $950K of Motif Bio plc ADRs stock for Q2 2019, down 54% quarter-over-quarter.
  • 3 funds opened new Motif Bio plc ADRs positions in Q2 2019 and 0 closed out, a net change of +3 holders.
  • The largest Motif Bio plc ADRs buyer in Q2 2019 was Renaissance Technologies, an estimated $253K added.

Based on aggregated 13F filings for Q2 2019.